R. Duijnhoven

发表

Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis

A. Hoes, M. D. De Bruin, A. de Boer, 2013, PLoS medicine.

The CErebro Placental RAtio as indicator for delivery following perception of reduced fetal movements, protocol for an international cluster randomised clinical trial; the CEPRA study

A. Khalil, A. Heazell, Sailesh Kumar, 2021, BMC Pregnancy and Childbirth.

Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials

B. Mol, H. Hagberg, J. V. D. van der Post, 2020, PLoS medicine.

Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial

S. Polinder, W. Melchers, R. van de Laar, 2020, BMC Cancer.

Potential Misinterpretation of Treatment Effects Due to Use of Odds Ratios and Logistic Regression in Randomized Controlled Trials

D. Grobbee, K. Moons, R. Groenwold, 2011, PloS one.

Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study

J. Fournier, S. Suissa, O. Klungel, 2014, Menopause.

Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study

J. Roovers, A. Lagro-Janssen, R. Duijnhoven, 2021, BJOG : an international journal of obstetrics and gynaecology.

Cost-Effectiveness of perioperative Vaginally Administered estrogen in postmenopausal women undergoing prolapse surgery (EVA trial): study protocol for a multicenter double-blind randomized placebo-controlled trial

J. Bosmans, A. Adriaanse, J. Roovers, 2021, BMC Women's Health.

Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial

P. Bossuyt, B. Mol, J. V. D. van der Post, 2019, BMJ.

Effect of Pessary vs Surgery on Patient-Reported Improvement in Patients With Symptomatic Pelvic Organ Prolapse: A Randomized Clinical Trial.

J. Roovers, A. Lagro-Janssen, R. Duijnhoven, 2022, JAMA.

Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial

J. Bosmans, P. Geomini, T. J. Clark, 2022, BMC Women's Health.

Levonorgestrel releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.

P. Bossuyt, B. Mol, J. W. van der Steeg, 2020, American journal of obstetrics and gynecology.

Effect of single‐ versus double‐layer uterine closure during caesarean section on postmenstrual spotting (2Close): multicentre, double‐blind, randomised controlled superiority trial

C. D. de Groot, J. Huirne, P. M. van de Ven, 2020, BJOG : an international journal of obstetrics and gynaecology.

Temporizing management vs immediate delivery in early‐onset severe preeclampsia between 28 and 34 weeks of gestation (TOTEM study): An open‐label randomized controlled trial

B. Mol, A. Franx, H. Scheepers, 2020, Acta obstetricia et gynecologica Scandinavica.

Elective induction of labour and expectant management in late-term pregnancy: A prospective cohort study alongside the INDEX randomised controlled trial

P. Bossuyt, J. V. D. van der Post, A. V. van Kaam, 2022, European journal of obstetrics & gynecology and reproductive biology: X.

Marketing Authorization Applications Made to the European Medicines Agency in 2018–2019: What was the Contribution of Real‐World Evidence?

C. Quinten, R. Flynn, R. Duijnhoven, 2021, Clinical pharmacology and therapeutics.

Long-term use of 5α-reductase inhibitors and the risk of male breast cancer

A. Hoes, P. Souverein, M. D. De Bruin, 2014, Cancer Causes & Control.

Working conditions in low risk nulliparous women in The Netherlands: are legislation and guidelines a guarantee for a healthy working environment? A cohort study

R. Painter, M. Kok, R. Duijnhoven, 2022, International Archives of Occupational and Environmental Health.

Carcinogenicity of Biopharmaceuticals

F. Bellanti, R. Duijnhoven, M. Kwa, 2015 .

Logistic regression and odds ratios as means to adjust for baseline incomparability’s in randomised controlled trials: description of the disadvantages, alternatives and frequency of use

R. Duijnhoven, 2012 .

Long-term use of 5α-reductase inhibitors and the risk of male breast cancer

A. Hoes, M. D. De Bruin, S. Straus, 2014, Cancer Causes & Control.

Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction

C. Naaktgeboren, J. Jakobsen, J. V. van Laar, 2020, JAMA network open.

Cognitive outcome in congenital central hypothyroidism: a systematic review with meta-analysis of individual patient data.

J. H. van der Lee, J. Limpens, R. Duijnhoven, 2020, European journal of endocrinology.

Treatment of women with heavy menstrual bleeding: Results of a prospective cohort study alongside a randomised controlled trial.

P. Geomini, M. Bongers, R. Duijnhoven, 2020, European journal of obstetrics, gynecology, and reproductive biology.

Working Conditions In Women With Multiple Pregnancy, The Impact On Preterm Birth And Adherence To Guidelines - A Prospective Cohort Study.

M. Frings-Dresen, E. Schuit, M. Spaanderman, 2022, American journal of obstetrics and gynecology.

Evaluation of a blended care programme for caregivers and working pregnant women to prevent adverse pregnancy outcomes: an intervention study

M. Frings-Dresen, B. Mol, M. Kok, 2021, Occupational and Environmental Medicine.

Risk Management Plans as a Tool for Proactive Pharmacovigilance: A Cohort Study of Newly Approved Drugs in Europe

H. Leufkens, A. Mantel‐Teeuwisse, R. Duijnhoven, 2014, Clinical pharmacology and therapeutics.

RCT COMPARING THE LNG-IUS VERSUS ENDOMETRIAL ABLATION IN WOMEN WITH HEAVY MENSTRUAL BLEEDING (MIRA)

B. Mol, P. Geomini, M. Bongers, 2018 .

Adjuvant VACcination against HPV in surgical treatment of Cervical Intra-epithelial Neoplasia (VACCIN study) a study protocol for a randomised controlled trial

S. Polinder, W. Melchers, R. van de Laar, 2020, BMC Cancer.